Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick J Raal

Showing results (11-20 of 185) with videos related to

Pageof 19
Sort By:
JCEM Case Reports|January 29, 2024
Unraveling the Whipple Triad: Non-Islet Cell Tumor-Induced HypoglycemiaFarzahna Mohamed, Frederick J Raal
Lancet (London, England)|February 26, 2013
Polygenic familial hypercholesterolaemia: does it matter?Evan A Stein, Frederick J Raal
Circulation|May 22, 2013
Insights into PCSK9, low-density lipoprotein receptor, and low-density lipoprotein cholesterol metabolism: of mice and manEvan A Stein, Frederick J Raal
Lancet (London, England)|September 2, 2023
Regression of cutaneous xanthomata in patient with homozygous familial hypercholesterolemia using novel therapiesBrett Stephen Mansfield, Frederick J Raal
Journal of Lipid Research|March 29, 2014
What matters most in pediatric familial hypercholesterolemia, genotype or phenotype?Frederick J Raal, Evan A Stein
Best Practice & Research. Clinical Endocrinology & Metabolism|May 21, 2014
Targeting LDL: is lower better and is it safe?Evan A Stein, Frederick J Raal
Current Cardiology Reports|September 20, 2015
Lipid-Lowering Drug Therapy for CVD Prevention: Looking into the FutureEvan A Stein, Frederick J Raal
Endocrinology and Metabolism Clinics of North America|November 30, 2014
New therapies for reducing low-density lipoprotein cholesterolEvan A Stein, Frederick J Raal
Clinical Chemistry|May 27, 2016
The Effects of Mipomersen on Inhibiting Hepatic VLDL Apolipoprotein B100 Synthesis and Propensity for Hepatic SteatosisFrederick J Raal, Evan A Stein
Current Opinion in Lipidology|October 7, 2021
Management of familial hypercholesterolemia in pregnancyDorothy F Graham, Frederick J Raal
Pageof 19

Showing results (11-20 of 185) with videos related to

Sort By:
Pageof 19
JCEM Case Reports|January 29, 2024
Unraveling the Whipple Triad: Non-Islet Cell Tumor-Induced HypoglycemiaFarzahna Mohamed, Frederick J Raal
Lancet (London, England)|February 26, 2013
Polygenic familial hypercholesterolaemia: does it matter?Evan A Stein, Frederick J Raal
Circulation|May 22, 2013
Insights into PCSK9, low-density lipoprotein receptor, and low-density lipoprotein cholesterol metabolism: of mice and manEvan A Stein, Frederick J Raal
Lancet (London, England)|September 2, 2023
Regression of cutaneous xanthomata in patient with homozygous familial hypercholesterolemia using novel therapiesBrett Stephen Mansfield, Frederick J Raal
Journal of Lipid Research|March 29, 2014
What matters most in pediatric familial hypercholesterolemia, genotype or phenotype?Frederick J Raal, Evan A Stein
Best Practice & Research. Clinical Endocrinology & Metabolism|May 21, 2014
Targeting LDL: is lower better and is it safe?Evan A Stein, Frederick J Raal
Current Cardiology Reports|September 20, 2015
Lipid-Lowering Drug Therapy for CVD Prevention: Looking into the FutureEvan A Stein, Frederick J Raal
Endocrinology and Metabolism Clinics of North America|November 30, 2014
New therapies for reducing low-density lipoprotein cholesterolEvan A Stein, Frederick J Raal
Clinical Chemistry|May 27, 2016
The Effects of Mipomersen on Inhibiting Hepatic VLDL Apolipoprotein B100 Synthesis and Propensity for Hepatic SteatosisFrederick J Raal, Evan A Stein
Current Opinion in Lipidology|October 7, 2021
Management of familial hypercholesterolemia in pregnancyDorothy F Graham, Frederick J Raal
Pageof 19